Form D · Biotechnology
Zekano Bio, Inc.
Wooodbridge, CT · CIK 0001874996
Offering snapshot reported Sep 1, 2021 · SEC filing
- Reported sold
- $50K Offering amount: $50K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 18, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 1, 2021 | Initial | $50,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-411929
Source: Form D, filed Sep 1, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jason Fisherman | Director, Executive |
| Uday Khire | Director, Executive |
| Peter Suzman | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4 Research Drive
Wooodbridge, CT, 06525
Wooodbridge, CT, 06525